<?xml version="1.0" encoding="UTF-8"?>
<fig id="vaccines-08-00142-f002" orientation="portrait" position="float">
 <label>Figure 2</label>
 <caption>
  <p>Enforced virus replication in dLN is essential to activate immunity. 
   <bold>A</bold>: Viral titers in dLN 16 h after 2 × 10
   <sup>6</sup> PFU s.c. VSV infection. (
   <italic>n</italic> = 6). 
   <bold>B</bold>: Quantitative detection of VSV-NP in dLN after infection as in 
   <bold>A</bold>. (
   <italic>n</italic> = 7–9). 
   <bold>C</bold>: Immunohistofluorescense staining of dLN sections of mice infected with 2 × 10
   <sup>6</sup> PFU VSV s.c. 16 h p.i. stained for VSV-G (red) and CD169 (blue). Scale bar 100 µm. One representative picture of each group from two experiments (
   <italic>n</italic> = 7–9) shown. 
   <bold>D</bold>: Relative expression of 
   <italic>Ifna2, Ifna4</italic> and 
   <italic>Ifnb1</italic> in draining lymph node obtained from infected mice as described in 
   <bold>A</bold>. (
   <italic>n</italic> = 7–9, 
   <italic>naïve</italic> WT mice 
   <italic>n</italic> = 4). 
   <bold>E + F</bold>: VSV neutralizing total IG (
   <bold>E</bold>) or neutralizing IgG (
   <bold>F</bold>) in mice subcutaneously infected with 2 × 10
   <sup>6</sup> PFU VSV. (
   <italic>n</italic> = 6–9) * 
   <italic>p</italic> &lt; 0.05 and ** 
   <italic>p</italic> &lt; 0.01 (Student’s t-test, 
   <bold>A</bold>,
   <bold>B</bold>,
   <bold>D</bold>), (Two-way-Anova, 
   <bold>E</bold>,
   <bold>F</bold>). Data are representative of two (
   <bold>A–F</bold>) experiments (mean ± SEM (
   <bold>A</bold>,
   <bold>B</bold>,
   <bold>D</bold>–
   <bold>F</bold>)).
  </p>
 </caption>
 <graphic xlink:href="vaccines-08-00142-g002" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
